The Win-Win Imperative: A Global Call to Make High-Value Cancer Care Affordable
Sep 01, 2026
View online
The Win-Win Imperative: A Global Call to Make High-Value Cancer Care Affordable
Trastuzumab Plus Pertuzumab Approved in EU for First-Line HER2-Positive Metastatic Breast Cancer
BeOne Medicines Reaches U.S. Government Agreement to Expand Access to Cancer Medicines
David Sebag-Montefiore: Exciting Milestone for the STAR-TREC Rectal Cancer Trial
Don Dizon’s Heartfelt Piece in NEJM Dedicated to Rachna Shroff’s Cancer Diagnosis
Event and Advocacy Opportunity: European Women Cancer Assembly 2026
What Trump’s FDA Pick Could Mean for Cancer Drug Regulation?
KWF Dutch Cancer Society Call for Validation of Biomarker Candidates 2027
Florida DOH Live Like Bella Pediatric Cancer Research Grants 2026–27
The Fundraising Gala: An Evening for Cure – OOTII CCCoE
Best of ASCO – Taipei 2026
The Voice of Oncology
Unsubscribe
|
Manage subscription
OncoDaily, P53 Inc.
867 Boylston Street, 5th Floor, Suite 1094, Boston, MA 02116
Copyright (C) 2023-2026. OncoDaily, P53 Inc. All rights reserved.
